Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors [Phase 2]
A Phase 2 clinical trial evaluating the safety and effectiveness of Terbium-161 DOTATATE for metastatic neuroendocrine tumors, currently rec…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue) [Phase 2]
A Phase 2 clinical trial evaluating guarana for fatigue in patients with neuroendocrine tumors and gynecologic cancers is currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors [Phase 1]
Phase 1 clinical trial update on the investigational agent BL-M14D1 for locally advanced or metastatic small cell lung cancer and a range of…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET [Phase 2]
A Phase 2 clinical trial is evaluating retreatment with Lutathera (lutetium Lu-177 dotatate) in patients with new progression of intestinal …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy [Phase 1, Phase 2]
A Phase 1/2 trial of CHM-2101, an autologous CDH17 CAR-T therapy, is evaluating safety and early efficacy in neuroendocrine tumors, colorect…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Sapu003 in Advanced mTOR-sensitive Solid Tumors [Phase 1]
Phase 1 trial update for Sapu003 in advanced mTOR-sensitive solid tumors, currently recruiting across multiple indications including metasta…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients [Phase 1]
Phase 1 study of NEUK203-13 in refractory neuroendocrine tumors and extensive-stage small cell lung cancer reports safety, tolerability and …
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Study of Etoposide-carboplatin in Combination With Pembrolizumab and Lenvatinib Maintenance in HG-NETs [Phase 2]
A Phase 2 clinical trial is evaluating etoposide-carboplatin with pembrolizumab and lenvatinib maintenance in high-grade neuroendocrine tumo…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases [NA]
A Mayo Clinic-led clinical trial investigates breathing practices to support brain and mental health in cancer and neurodegenerative disease…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: 18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms
A clinical trial is evaluating the PET imaging tracer 18F-AlF-NOTA-Octreotide for neuroendocrine tumors; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors [Phase 2]
CVM-1118 is being studied in a Phase 2 trial for advanced neuroendocrine tumors. The study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms [Phase 4]
A Phase 4 prospective real-world trial of surufatinib in patients with advanced neuroendocrine tumors or neuroendocrine neoplasms is current…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Neuroendocrine Tumors - Patient Reported Outcomes
Clinical trial update on patient-reported outcomes for neuroendocrine tumors in the NCT05064150 study sponsored by the University of Iowa; t…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET) [Phase 1]
Phase 1 clinical trial evaluating the combination of SVV-001 with nivolumab and ipilimumab in patients with poorly differentiated neuroendoc…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors [Phase 1]
Phase I clinical trial update evaluating dose, pharmacokinetics, and safety of Lutetium-177-edotreotide therapy in pediatric participants wi…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: A Study to Test Different Doses of BI 764532 in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3 [Phase 1]
Phase 1 study evaluating different doses of BI 764532 in DLL3-positive small cell lung cancer and other neuroendocrine tumors; the trial is …
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: CapTemY90 for Grade 2/3 NET Liver Metastases [Phase 2]
A Phase 2 clinical trial evaluating CapTemY90 for liver metastases from neuroendocrine tumors (Grade 2) is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions
Clinical trial update on recruiting for a study evaluating endoscopic ultrasound-guided radiofrequency ablation of upper gastrointestinal tr…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NEN [NA]
A clinical trial is evaluating PET imaging with zirconium-labelled girentuximab in patients with hepatocellular carcinoma, intrahepatic chol…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Effect of OFA, OSA Versus Opioid-based Anesthesia on NETs and Cancer Cell Malignancy After Colorectal Cancer Surgery [NA]
This clinical trial update describes a study comparing opioid-free and opioid-sparing anesthesia with opioid-based anesthesia in colorectal …
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors [Phase 2]
This Phase 2 clinical trial update reports recruitment for an alternative cabozantinib dosing schedule in metastatic renal cell carcinoma an…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide
RegisterNET is a registry for neuroendocrine tumors in the USA and worldwide. It is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
An ongoing NCI-sponsored observational study to collect tissue samples and characterize the natural history of neuroendocrine neoplasms, inc…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating a Gallium-68 labeled FAPI tracer (Ga-FAPI-04) PET/CT for imaging patients with high-grade neuroen…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit [Phase 1]
Phase 1 study evaluating NN3201, a c-Kit targeted antibody-drug conjugate, in advanced and/or metastatic solid tumors expressing c-Kit; curr…